Effectiveness and safety analysis of Danggui Shaoyao Powder for the treatment of non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled clinical trial

MLA

Qian Huang, et al. “Effectiveness and Safety Analysis of Danggui Shaoyao Powder for the Treatment of Non-Alcoholic Fatty Liver Disease: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.” BMC Complementary Medicine and Therapies, vol. 23, no. 1, Apr. 2023, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s12906-023-03948-3.

APA

Qian Huang, Ziming An, Xin Xin, Qinmei Sun, Siting Gao, Sheng Lv, Xiao Xu, Shuohui Yang, Fang Lu, Jie Yuan, Yu Zhao, Yiyang Hu, Ping Liu, & Qin Feng. (2023). Effectiveness and safety analysis of Danggui Shaoyao Powder for the treatment of non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled clinical trial. BMC Complementary Medicine and Therapies, 23(1), 1–8. https://doi.org/10.1186/s12906-023-03948-3

Chicago

Qian Huang, Ziming An, Xin Xin, Qinmei Sun, Siting Gao, Sheng Lv, Xiao Xu, et al. 2023. “Effectiveness and Safety Analysis of Danggui Shaoyao Powder for the Treatment of Non-Alcoholic Fatty Liver Disease: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.” BMC Complementary Medicine and Therapies 23 (1): 1–8. doi:10.1186/s12906-023-03948-3.